OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

To reveal more filter options, please select whether you would like to review Active or Closed projects:

Clear
Investigator: Larry Altstiel

1 Projects | 1 Researchers | $164,750 Invested

2013

Provectra Therapeutics Inc.

Larry Altstiel

Adeno-Associated Virus Gene Therapy of Progranulin-Related Frontotemporal Dementia

  • Funding Amount: $164,750
  • Organization Type: Biotechnology/For Profit
  • Program: Drug Discovery
  • Status: Closed